Virtual Medicinal Product (VMP)
-
Alteplase 2mg powder and solvent for solution for injection vials
Name Details
Current Name
Alteplase 2mg powder and solvent for solution for injection vials
|
Start Date
06-06-2011
|
End Date
|
|
Abbreviated Name
Alteplase 2mg inj vials
|
Start Date
06-06-2011
|
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder and solvent for solution for injection
- Ontology Form/Route
- solutioninjection.intravenous, solutioninfusion.intravenous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
B01AD02
BNF |
Current BNF
02100200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
02100200
|
Start Date
18-01-2012
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
19180011000001103 |
06-06-2011 |
|
VMP Ingredients
VMP ingredients table
Alteplase |
Based on Ingredient Substance |
|
2 mg |
|
Name
Alteplase
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
2
Strength and UOM (Dmr)
Parent Products
-
VTM
Alteplase
-
VMP
(Current) Alteplase 2mg powder and solvent for...
Virtual Medicinal Product Pack (VMPP) Information